A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam

Clinical trial NCT07444476 · RECRUITING

Trial details

NCT number: NCT07444476
Sponsor: Biogen
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Spinal Muscular Atrophy

Start date: 2026-04-03
Primary completion: 2028-06-23
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.